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Tissue-specific gene expression requires modulation of nucleosomes, allowing transcription factors to occupy cis elements that
are accessible only in selected tissues. Master transcription factors control cell-specific genes and define cellular identities, but it
is unclear if they possess special abilities to regulate cell-specific chromatin and if such abilities might underlie lineage determi-
nation andmaintenance. One prevailing view is that several transcription factors enable chromatin access in combination. The
homeodomain protein CDX2 specifies the embryonic intestinal epithelium, through unknownmechanisms, and partners with
transcription factors such as HNF4A in the adult intestine. We examined enhancer chromatin and gene expression following
Cdx2 orHnf4a excision in mouse intestines. HNF4A loss did not affect CDX2 binding or chromatin, whereas CDX2 depletion
modified chromatin significantly at CDX2-bound enhancers, disrupted HNF4A occupancy, and abrogated expression of neigh-
boring genes. Thus, CDX2maintains transcription-permissive chromatin, illustrating a powerful and dominant effect on en-
hancer configuration in an adult tissue. Similar, hierarchical control of cell-specific chromatin states is probably a general prop-
erty of master transcription factors.
Cell identities and functions in multicellular organisms repre-sent the outcome of interactions between transcription fac-
tors (TFs) and chromatin. Because nucleosomes restrict access of
genomic DNA (1), TFs must overcome a steric barrier at the cis-
regulatory elements of tissue-specific genes during development
and preserve access in adult tissues. Sequence-specificDNA-bind-
ing proteins that initiate chromatin access at tissue-specific en-
hancers in embryos or differentiating cells are known as pioneer
factors. Although pioneer factors recruit additional TFs, they do
not necessarily affect long-term nucleosome organization, and
they may be dispensable after tissues are specified (2–4). For ex-
ample, FOXA proteins initiate liver development and facilitate
hormone responses in other epithelia but are not required to
maintain the adult liver (4). Indeed, the determinants of contin-
uous, cell-type-specificDNA access within chromatin are unclear,
and in one prevalent view, multiple TFs cooperate indirectly,
without overt hierarchies, to maintain transcription-permissive
chromatin (4–7).
Cell fate and function depend critically on a limited number of
lineage-restricted TFs that control tissue-specific transcriptional
programs. For example, MYOD1, MYOG, and MYF5 in muscle
(8, 9) or GATA1, CEBPA, and SFPI1 in blood (10, 11) function at
the apex of transcriptional hierarchies and regulate innumerable
tissue-specific genes. TFs such asMYOD1,CEBPA, and SFPI1 also
tailor cell-specific responses to extrinsic signals (12, 13), but the
basis for the sum of these potent in vivo activities remains unclear.
One hypothesis is that suchTFs, which are often regarded as “mas-
ter regulators,” control cell lineages by virtue of a particular role in
inducing or maintaining open, active chromatin at tissue-specific
cis elements (5).
The intestine-specific homeodomain protein CDX2 is one
such TF that specifies embryonic intestinal epithelium (14), im-
parts intestinal character to stomach cells (15), and maintains
adult intestinal function and identity (16–18). Consistent with the
idea that these properties reflect coordinated control of many in-
testine-specific genes (19), we previously showed that CDX2 oc-
cupies more than 12,000 sites (P  105; 2,885 high-confidence
sites at P 1010) in the genome of adult mouse intestinal villus
cells (18). Most of this binding occurs far from transcriptional
start sites (TSSs) within a chromatin configuration indicative of
active enhancers: two well-positioned nucleosomes enriched with
histone H3 dimethylated on lysine 4 (H3K4me2) that flank an
interval of apparent nucleosome depletion (20–22). Moreover, in
human intestinal Caco-2 cells, CDX2 often binds DNA in close
proximity to GATA6, HNF4A, and other tissue-restricted TFs
(22). HNF4A, in particular, is highly expressed in mature intesti-
nal villus cells and binds cis elements of genes associated with
terminal cell differentiation (23, 24). The DNA sequence motif
that HNF4A favors is also highly enriched at CDX2 binding re-
gions in the mouse intestine (18). These observations in human
and murine cells are consistent with the emerging view that small
groups of lineage-restricted TFs assemble on distant cis-regulatory
modules to regulate tissue-specific genes (25).
The activities of master TFs at tissue-specific chromatin ele-
ments in general and at cis-regulatory modules in particular re-
main unclear. In part, this is because reciprocal TF relationships
with each other and with chromatin are challenging to investigate
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in vivo. Here, we useCdx2,Hnf4a, and compoundmutantmice to
investigate individual TF requirements in facilitating binding of
partner TFs and in maintaining chromatin access.
MATERIALS AND METHODS
ChIP. Chromatin immunoprecipitation (ChIP) was performed as de-
scribed previously (18). Epithelial cells were isolated from villi in themid-
dle one-third of the mouse small intestine (jejunum) using EDTA to sep-
arate epithelium from underlying lamina propria, as reported previously
(26). Villi were separated from crypts by retaining vortex fractions that
failed to pass through a 70-m-pore-size filter. For TF ChIP, villus frac-
tions were first cross-linked using 1% formaldehyde in phosphate-buff-
ered saline (PBS) for 15 min at 4°C and then for 35 min at room temper-
ature, followed by sonication in lysis buffer (1% SDS, 10 mM EDTA, 50
mMTris-HCl, pH 8.1) using a Bioruptor until most DNA fragments were
between 200 to 500 bp in length, as determined by agarose gel electropho-
resis. Cell lysates were diluted 6- to 10-fold in binding buffer (1% Triton
X-100, 2mMEDTA, 150mMNaCl, 20mMTris-HCl, pH 8.1), incubated
with antibody (Ab)-coupled magnetic beads for 16 h at 4°C, and washed
six times. DNA was recovered, and cross-links were reversed in 1% SDS
and 0.1 M NaHCO3 at 65°C for 8 h. For H3K4me2 ChIP, mononucleo-
some fractions of isolated villus cells were prepared by treatment with
MNase until most of the DNA appeared by agarose gel electrophoresis to
havemononucleosome length. Samples were dialyzed in 1,000 volumes of
radioimmunoprecipitation assay (RIPA) buffer and used in ChIP as de-
scribed above, following published protocols (20, 22). Six micrograms of
Ab was used for each ChIP: CDX2 (catalog item BL3194; Bethyl Labora-
tories), HNF4A (catalog item 6547; Santa Cruz Biotechnology), or
H3K4me2 (catalog item 07-030; Millipore). DNA libraries were prepared
for sequencing according to the manufacturer’s recommendations (Illu-
mina).
Motif analysis at TF binding sites detected by ChIP-Seq. To analyze
DNA motif content in TF-bound sites, we ran the motif-based interval
screener using the PSSM (MISP) tool in the Cistrome project (http:
//cistrome.org/ap/) on CDX2-only, HNF4A-only, and cooccupied sites.
This tool computes the log-fold difference between the probabilities
of true and background motif enrichments at a given site, providing
Motif-Scan scores along with their specific locations; the background fre-
quency is obtained using a zero-order or first-order Markov chain. A
Motif-Scan score of 100 was empirically selected as the lower limit; i.e.,
scores of 100 were regarded as insignificant for further consideration.
Motif content was quantified as the fraction of binding sites with the
presence of themotif at a given quantile-based score cutoff with respect to
all binding sites (see Fig. S1 in the supplemental material).Whenmultiple
instances of a motif were detected in a TF binding site, only the one with
the highest score was considered.
Determination of TF binding and cooccupancy.Aftermapping onto
the reference mouse genome (UCSC assembly mm9, NCBI build 37),
ChIP with high-throughput sequencing (ChIP-Seq) fragments with two
or fewer mismatches in each library were kept for identifying TF binding
sites, usingMACS (model-based analysis of ChIP-Seq), version 1.4.0 beta
(27), and consideration of local chromatin bias. Resulting WIG files were
visualized in the Integrative Genomics Viewer (28). TF cooccupancy was
determined by considering the distance between nearest-neighbor bind-
ing summits (P 105) at increasing distances (Fig. 1C).
Calling positions of H3K4me2 mononucleosomes and identifying
functional enhancers from different nucleosome dynamics in control
and mutant mice. To detect H3K4me2-marked nucleosomes, NPS
(nucleosome positioning from sequencing) software (29) was applied to
H3K4me2 ChIP-Seq data on mononucleosomes from wild-type (WT),
Cdx2/,Hnf4a/, and Cdx2/;Hnf4a/ intestinal epithelium. Dis-
tances of2 kb from transcription start sites (TSSs) of RefSeq genes were
considered to identify potential enhancers. Using the Tagtab application
in the BINOCh software package (30), groups of two to three consecu-
tively positioned nucleosomes with centers within a 450- to 600-bp span
were identified from an H3K4me2 profile in WT intestines. Each nucleo-
some group was scored to quantify its change in mutant chromatin rela-
tive to theWT, i.e., as less or more accessible for TF binding. The nucleo-
some stabilization-destabilization (NSD) score, multiplied by 1,000,
produces positive values for chromatin that is more accessible for TF
binding under a condition and negative values when sites are less accessi-
ble.
Composite analysis of H3K4me2 nucleosomes in regions occupied
by CDX2, HNF4A, or both TFs. To assess the impact of TF deletion on
chromatin represented by H3K4me2-marked nucleosomes, we plotted
average ChIP-Seq signals for H3K4me2 in WT and mutant intestinal vil-
lus cells within the indicated distance from TF binding summits. ChIP-
Seq wiggle traces were normalized with respect to the total of 2  107
uniquely mapped tags, and average traces were plotted using CEAS (31).
This package was also applied to determine the binding distribution of
HNF4A, CDX2, or both TFs with respect to TSSs (Fig. 1F). The SeqPos
algorithm (32), available at http://cistrome.dfci.harvard.edu, was used to
identify motifs enriched within HNF4A binding sites.
Immunodetection. Immunoblotting and immunostaining were per-
formed as described previously (18). CDX2 antibodies were used at dilu-
tions of 1:1,000 (Bethyl Laboratories) or 1:20 (Biogenex Laboratories).
HNF4A antibody (6547; Santa Cruz Biotechnology) was applied at a
1:1,000 dilution for immunoblotting and immunostaining.
Measuring significant changes inbindingofoneTF in the absenceof
another. The average CDX2 and HNF4A ChIP-Seq signals at cooccupied
sites were first obtained to determine the average width of binding sites.
The average peak width, defined as the distance between the peak bound-
aries at 10% of the average peak height, was 370 bp for CDX2 and 350 bp
forHNF4A.We therefore considered 360 bp as the average peak width for
fair comparison between the two TFs. ChIP-Seq tags from wild-type and
TF-depleted intestines were then counted 180 bp downstream and 180 bp
upstream of the binding summit and log2 fold changes between wild-type
and mutant ChIP-Seq tag counts were calculated to assess the impact of
one TF’s absence on the other factor’s binding. In the following equations,
FC is fold change, n and m represent ChIP-Seq tag counts for CDX2
and HNF4A, respectively, and KO (for knockout) refers to the mutant,
TF-depleted intestine: log FCCDX2  log2(nWT/nHNF4AKO) and log
FCHNF4A  log2(mWT/mCDX2KO).
Defining background regions. To estimate the direct impact of one
TF’s absence on the other TF’s binding at sites they cooccupy in wild-type
intestinal cells, it was necessary first to define an internal control set of
regions occupied by only one TF; control regions that harbor low ChIP-
Seq signals for the other TF enable precise capture of the primary impact
of TF depletion and reduce spurious effects. To estimate the genomic
background for residual TF binding, we measured ChIP-Seq signals for
CDX2 and HNF4A on regions that showed high H3K4me2 enrichment
but no evidence for binding of either TF (MACS P values of105) and
regarded the median ChIP-Seq values on those regions as the respective
“noise thresholds.” Similarly, we defined “signal thresholds” for each TF
by estimating the median ChIP-Seq signal in CDX2 and HNF4A binding
sites (MACSP value of105). Thus, binding sites unique toCDX2 show
a HNF4A ChIP-Seq signal lower than the HNF4A noise threshold and a
CDX2 ChIP-Seq signal higher than the CDX2 signal threshold; binding
sites unique to HNF4A are defined similarly. Because we observed quan-
titative continua of TF binding, these thresholds allow more stringent
categorization of binding events as solitary or cooccupied. Genomic re-
gions with high H3K4me2 signal but no CDX2 or HNF4A binding were
used to calculate the null distributions of scores for altered chromatin
structure. These distributions, which represent the basal variation inmea-
sured chromatin under any condition, are not attributable to CDX2 or
HNF4A binding.
Comparing differences in TF binding in regions cooccupied by
CDX2andHNF4Awith those in sites occupiedbyonly oneof theseTFs.
After computing the log fold changes in TF binding between cooccupied
and singly bound regions, visual observation indicated that the distribu-
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tions of the log fold changes were highly shifted toward the negative side.
We therefore performed a nonparametric statistical test (Mann-Whitney)
to assess the significance of reduced binding in cooccupied regions with
respect to the reduced signal in singly bound sites.
Comparing changes in chromatin structure between WT and mu-
tant intestines in sites cooccupied by CDX2 and HNF4A with those in
sites bound by a single TF. Changes in chromatin structure were deter-
mined by the NSD scoring system (20), and scores were multiplied by
1,000. Briefly, NSD scores represent the difference between H3K4me2
signal on flanking nucleosomes relative to the adjacent center nucleo-
somes betweenWT andmutant conditions. Scores for the change in chro-
matin state were compared using a Mann-Whitney test for significance
because the score distributions were highly asymmetric. NSD calculations
were also applied to arrange genomic regions from most accessible (pos-
itive NSD scores) to least accessible (negative NSD scores) in Cdx2/
intestine. Figure 6E plots the frequency of TF binding within each bin of
750 NSD-scored chromatin regions relative to the expected number of
binding regions in each bin if no binding tendency is observed. Histo-
grams in Fig. 7E enumerate the number of regions within each NSD-
scored bin.
Detecting differential gene expression. Epithelial cells were isolated
from the middle one-third of WT and mutant small intestines, using the
EDTA-based method described above, in the section on ChIP analysis;
total RNA was isolated using TRIzol and processed and hybridized to
FIG 1 CDX2 andHNF4A bind intestinal epithelial cell DNA in close vicinity in areas of active chromatin. (A) CDX2 andHNF4A binding in intestinal villus cells
from WT mouse jejunum, determined by ChIP-Seq peaks called at a P value of 105. Overlapping DNA occupancy was evident in 2,783 regions. (B) The
HNF4A recognition motif was significantly enriched within HNF4A binding regions. (C) Cumulative plots showing the fraction of TF binding sites detected by
ChIP-Seq (P 105) within the indicated distance from the partner factor’s binding summit. Beyond 300 bp (dotted line), the frequency with which partner
factors occupy the same genomic region decreased to the same level as background binding across the genome. Accordingly, 300 bp was selected as a cutoff for
considering an interval to be cooccupied by CDX2 andHNF4A. (D) Histogram depicting the frequency at which HNF4A ChIP-Seq peaks appear within a 50-bp
window of the indicated distance from the summit of a CDX2 binding site. The two factors frequently bind within 300 bp of each other (gray bars), and such
clustering is not evident for CDX2 and random genomic regions equal in number and length to HNF4A binding sites (black bars). (E) ChIP-Seq tags tallied over
a representative 1.5-Mb region on mouse chromosome 1 illustrate binding of only HNF4A (blue), only CDX2 (red), or both TFs. (F) Genomic distribution of
HNF4A occupancy without (left) and with (right) nearby CDX2 binding, showing that HNF4A largely binds DNA in adult mouse intestinal cells far from gene
promoters. (G)Composite plots of theH3K4me2ChIP-Seq signal surrounding TF binding summits. Average sequence counts were determined in relation to the
centers of TF occupancy, indicated as 0, and plotted for each class of binding regions: CDX2 only, HNF4A only, or both TFs (cooccupied). H3K4me2 enrichment
on two well-positioned nucleosomes that flank a region of diminished signal and TF occupancy delineate active chromatin in presumptive enhancers.
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Affymetrix Mouse Genome 430 2.0 arrays as described previously (22).
RNA expression data fromWT (n 4),Cdx2/ (n 3),Hnf4a/ (n
2), and Cdx2/; Hnf4a/ (n 3) samples were preprocessed with the
robust multiarray average (RMA) software within the Affymetrix package
(version 1.24.2) of BioConductor (33) to determine the background and
to perform quantile normalization for comparison across samples. The
Limma package (34) was used to identify transcripts expressed at levels
significantly different from controls at a 5% false discovery rate (FDR).
Association between differential gene expression and TF binding.
To infer the association of TF bindingwith changes in gene expression, we
first counted the number of binding sites for CDX2, HNF4A, or both TFs
within 20 kb of annotated TSSs for each RefSeq gene. Genes were then
ranked according to the significance level for altered expression inmutant
samples (P values of Limma analysis) from the most reduced to the most
increased and grouped into bins of 100 genes each (see the red-green heat
map in Fig. 3B). The average number of TF binding sites was calculated
near the genes in each bin and normalized with respect to the average
number of binding sites for genes that did not change in mutant samples,
i.e., genes with FDR values larger than 50% (see the yellow heat map in
Fig. 3B).
Microarray data accession number. All data are deposited in the
Gene Expression Omnibus (GEO) under accession number GSE34568.
RESULTS
In vivo cooccupancy of intestinal TFs ondistant enhancerDNA.
Wefirst examinedHNF4Aoccupancy in cells freshly isolated from
wild-type (WT) mouse intestinal villi, using chromatin immuno-
precipitation and DNA sequencing (ChIP-Seq) to identify 22,327
binding sites (P  105; 8,734 sites at P  1010) (Fig. 1A). The
HNF4A consensus motif was highly enriched in these regions
(Fig. 1B). DNA-binding motif analysis further revealed enrich-
ment of CDX2 motifs in HNF4A binding regions detected by
ChIP-Seq and vice versa, as well as enrichment of both motifs in
regions that showed binding by both TFs (see Fig. S1 in the sup-
plementalmaterial). These findings imply thatHNF4A andCDX2
come in direct contact with DNA but also allow for the possibility
that some binding occurs through intermediary factors. To set a
distance within which to regard regions as cooccupied by the two
TFs, we determined the cumulative rate of nearby TF binding.We
raised the distance from HNF4A or CDX2 binding summits in-
crementally and calculated the fraction of sites that bound the
other TF within each interval (Fig. 1C). This analysis showed rap-
idly increasing cooccupancy at distances under 300 bp, whereas
binding frequencies of eachTFbeyond this intervalwere similar to
those in the genome at large. On this basis we selected 300 bp as an
empirical cutoff distance for TF cooccupancy, noting several fea-
tures. First, 300 bp approximates the length of DNA a displaced
nucleosomemight expose in accessible chromatin. Second, within
the 300-bp interval, we observed no particularly favored distance
between CDX2 and HNF4A binding summits (Fig. 1D). Third,
more than 12% of HNF4A binding occurred near CDX2-occu-
pied sites, and nearly a quarter of all CDX2 binding in vivo oc-
curred within 300 bp of HNF4A and often closer (Fig. 1D). This
degree of cooccupancy is similar to reports of TF convergence at
cis elements in other contexts (35–37), and sample ChIP-Seq data
illustrate both separate and joint occupancy of CDX2 andHNF4A
in the intestinal cell genome (Fig. 1E). Most HNF4A occupancy,
with or without nearby CDX2 binding, occurred more than 2 kb
away from transcription start sites (TSSs), in intergenic regions
and introns (Fig. 1F).
Cooccupancy in 300-bp windows far from gene promoters
suggests that CDX2 and HNF4A bind functional enhancers (38).
Additional features of active cis elements include heightened nu-
clease sensitivity, signifying nucleosome depletion, and histone
modifications associated with transcriptional activation, such as
histone H3 methylated at lysine 4 (H3K4me1), H3K4me2, and
histone H3 acetylated at lysine 27 (H3K27Ac) (21, 39–42). To
identify such enhancers, we performed ChIP-Seq for H3K4me2
on mononucleosome fractions of intestinal villus cell chromatin.
The H3K4me2 mark appears on promoters as well as enhancers,
and H3K4me2-marked nucleosome pairs are known to flank reg-
ulatory elements (20–22, 39). Among well-positioned H3K4me2-
marked nucleosome pairs, nearly 150,000 pairs were located 2
kb from TSSs, that is, away from promoters and in candidate
distant enhancers. At least 32% of CDX2 binding, 43% of HNF4A
binding, and 59%of CDX2 andHNF4A cooccupancy in intestinal
cells, all detected at a P value of105, fell between such nucleo-
some pairs (Fig. 1G). The presence of thousands of H3K4me2-
marked sites that CDX2 and HNF4A occupy in intestinal cells
allowed us to adopt a genetic approach to investigate the require-
ment of each TF for the other factor’s binding to DNA and in
preserving chromatin marks.
Concerted activator functions of HNF4A and CDX2. CDX2
primarily activates intestinal genes (18). To determine HNF4A
activity, we crossed mice carrying a floxed Hnf4a allele (43) with
Villin-CreER-T2 transgenic mice (44), which express tamoxifen-
dependent Cre recombinase in the intestine (Fig. 2A). Tamoxifen
efficiently depleted HNF4A fromHnf4aFl/Fl; Villin-CreER-T2 intes-
tines (Fig. 2B), and, in agreement with published reports (45, 46),
themutant epithelium remained largely intact (Fig. 2C), with only
small increases in goblet and replicating crypt cells (Fig. 2D and E).
Next, we examined HNF4A occupancy in wild-type intestines
with respect to gene expression changes in Hnf4a-null intestinal
cells. HNF4A binding correlated with genes that were reduced in
mutant mice but not with those that were increased or unaltered
(Fig. 2F), implying that HNF4A also mainly activates genes.
Extending this analysis to double mutant mice, we observed
that loss of bothHNF4A and CDX2 inCdx2Fl/Fl;Hnf4aFl/Fl;Villin-
CreER-T2 intestines affected villus height and structure (Fig. 3A)
more profoundly than loss of eitherHNF4A (Fig. 2) or CDX2 (18)
alone. The detailed phenotype of these compound mutant mice
will be reported elsewhere (A. San Roman et al., unpublished
data). More germane to the topic of the present study, the com-
bined loss of CDX2 and HNF4A affected the levels of nearly 4,000
transcripts (Fig. 3B, top) (false discovery rate of 5%). Binding of
both proteins in WT intestinal villi correlated only with tran-
scripts that declined in themutant gut (Fig. 3B, bottom), confirm-
ing their respective activator functions. Nearly 70% of genes with
reduced expression in the double mutant intestines showed bind-
ing of CDX2, HNF4A, or both TFs within 20 kb (Fig. 3B), which
implies that they stimulate transcription directly, often in concert;
this likely contributes toward defective villus structure in double
mutant intestines (Fig. 3A). Thus, CDX2 and HNF4A cooccu-
pancy at hundreds of distant foci of active chromatin is associated
with optimal expression of adjoining intestinal genes.
Nonreciprocal requirements for TF binding in vivo. We as-
sessed DNA occupancy of each TF inmouse intestinal villi lacking
the other protein. Absence of HNF4A did not materially alter
CDX2 expression (Fig. 4A), and ChIP-Seq of WT and Hnf4a/
intestines revealed little effect on global CDX2 occupancy, either
at sites without nearby HNF4A binding or at sites where the two
TFs normally cooccupy DNA within 300 bp (Fig. 4B). A site-by-
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FIG 2 HNF4A functions as a transcriptional activator in intestinal epithelium. (A) Schema for inducible, intestine-specific depletion of HNF4A in vivo. (B)
Immunostaining verifies efficient HNF4A loss in intestinal epithelium after tamoxifen-induced Cre recombination. (C) Hematoxylin and eosin staining shows
that Hnf4a/ gut epithelium is overtly intact. (D) The proportions of Ki67 proliferating crypt cells and Alcian blue-avid goblet cells are slightly increased in
Hnf4a/ gut epithelium, as others have reported. Scale bar, 30 m. (E) The small but significant increase in Ki67 and goblet cells was quantified by counting
labeled cells (data represent the mean cell counts 	 standard deviations from 3 mice; *, P  0.05; ***, P  0.001). (F) HNF4A activates transcription in
intestinal villi. We partitioned all transcripts, measured by microarray analysis (top heat map), in bins of 100, from those most reduced inHnf4a/ intestines
(green) to thosemost increased (red) and calculated theHNF4Abinding frequency near these groups of 100 genes in ChIP-Seq analysis ofWT intestines (bottom
heat map). HNF4A binding was highest near genes whose levels drop with HNF4A loss.
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site comparison of CDX2 binding in Hnf4a/ intestines further
revealed insignificant differences in occupancy between sites that
ordinarily bind onlyCDX2 and those that engage bothTFs; signals
in both cases were similar in WT and mutant intestines (Fig. 4C
and D).
In contrast, CDX2 loss reduced HNF4A binding for two seem-
ingly distinct reasons. First, extensive CDX2 binding at theHnf4a
locus in WT intestines (Fig. 5B) suggests that CDX2 regulates
Hnf4a expression directly. In agreement with this idea,Hnf4a lev-
els were slightly lower in the Cdx2/ gut (62.8% of wild-type
transcript levels by microarray analysis; P 1.18 104 as com-
puted by Limma), and both immunoblotting and immunostain-
ing showed a commensurate decline in protein levels (Fig. 5A).
Reflecting the lower protein level, HNF4A occupancy was mod-
estly reduced at sites where it normally binds DNAwithout CDX2
nearby (Fig. 5C and F, left). Second, DNA binding was severely
affected at sites where CDX2 and HNF4A ordinarily cooccupy
DNA (Fig. 5C and F, right). For example, HNF4A bindingwas lost
at the Homer2, Ms4a8a, and Aw112010 loci, where CDX2 and
HNF4A cooccupyDNA, but barely reduced at the linkedWhamm
locus orMs4a8a promoter, which do not bind CDX2 (Fig. 5D and
E; see also Fig. S2A in the supplemental material). Indeed, site-by-
site analysis indicated highly significant differences between bind-
ing of HNF4A at cooccupied regions and its binding at sites where
it normally occupies DNAwithout nearby CDX2 (Fig. 5F). Taken
together, these data show that HNF4A is dispensable for CDX2
binding but that CDX2 is necessary forHNF4Abinding, especially
at sites where the two proteins cooccupy DNA.
Effect of CDX2 deficiency on chromatin at sites of HNF4A
cooccupancy.The spacing betweenCDX2 andHNF4A binding in
vivo (Fig. 1D) or betweenCDX2 andHNF4A recognitionmotifs in
cooccupied regions in silico varies considerably in a distribution
that suggests no obviousmechanism for direct cooperativity in TF
binding. Instead, TF occupancy commonly coincided with the
space between flanking H3K4me2-marked nucleosomes (Fig. 1D
and G), suggesting indirect cooperativity mediated through chro-
matin (7, 47). To examine this possibility, we used H3K4me2
ChIP-Seq to examine the chromatin configuration in mutant in-
testines, specifically assessing H3K4me2 signals near regions that
bind both CDX2 and HNF4A in WT cells. Tamoxifen-induced
HNF4A depletion had no effect on the active chromatin configu-
ration at cooccupied regions (Fig. 6A); H3K4me2 marks on sepa-
rated, well-positioned nucleosomes were preserved. In Cdx2/
villi, however, this characteristic H3K4me2 profile around TF-
binding sites was notably diminished at cooccupied regions (Fig.
6B). Furthermore, the nucleosomal H3K4me2 profiles in these
regions were similar in Cdx2/ and Cdx2/; Hnf4a/ intesti-
nal villus cells (Fig. 6C), indicating that HNF4A adds little to the
dependence on CDX2. Thus, CDX2 but not HNF4A is necessary
to maintain transcription-permissive chromatin at hundreds of
distant intestinal cis elements in vivo. The finding that CDX2 loss
reduces expression of most linked genes (Fig. 3B) suggests that
this activity underlies its transcriptional regulatory function.
ChIP-Seq traces fromCdx2/ intestinal villi (Fig. 6D; see also
Fig. S2B in the supplemental material) illustrate concomitant dis-
ruption ofHNF4A binding andH3K4me2 signals at sites of CDX2
cooccupancy. Importantly, in these and other examples, HNF4A
binding and H3K4me2 are not affected at sites where CDX2 does
not bind DNA. To determine if the association between disrupted
HNF4A binding and disrupted H3K4me2 is general, we assessed
the concordance between the two variables. In the graph in Fig.
6E, all paired nucleosomes are arrayed serially in bins of 750 pairs
according to the nucleosome stabilization-destabilization score
(NSD), which ranks each nucleosome pair according to the mag-
nitude of difference between WT and Cdx2/ intestinal epithe-
lium (20); pairs that showed loss of theH3K4me2 configuration in
Cdx2/ intestine are represented to the right, and those showing
increased H3K4me2 signal in Cdx2/ intestine are shown to the
left. In WT intestines, HNF4A and CDX2 most often cooccupy
DNA in regions that require CDX2 for an active H3K4me2 con-
figuration (Fig. 6E, purple curve increasing to the right). In
Cdx2/ intestinal cells, HNF4A occupancy was dramatically re-
duced in regions with altered chromatin but was largely preserved
in areas where the H3K4me2 configuration was unaffected
(Fig. 6E, black line). These data suggest an intimate association
between HNF4A occupancy and CDX2-dependent chromatin
states.
To examine this relationship site by site, we generated scatter
plots of TF binding and chromatin H3K4me2 at every site of
CDX2 and HNF4A cooccupancy. Each dot in Fig. 6F and G rep-
resents the effect at a single site of loss of one TF on the nucleo-
someH3K4me2 configuration (x axis) and on binding of the part-
ner TF (y axis). Thus, the minimal effect of HNF4A loss on the
H3K4me2 signal or CDX2 binding results in even distribution of
dots around the (0, 0) coordinate, reflecting intrinsic signal vari-
ance with few outliers (Fig. 6F). In contrast, Cdx2/ dots are
FIG 3 (A) Immunostaining demonstrates that both CDX2 and HNF4A are
efficiently depleted in Cdx2-Hnf4a double mutant mice after tamoxifen treat-
ment. Scale bar, 30 m. Note the reduced villus height in the mutant tissue
relative to that of the control. (B) mRNA expression changes observed in
Cdx2-Hnf4a double mutant intestines are depicted in a heat map, similar to
that in Fig. 2F, with transcripts that decrease arrayed on the left (green) and
those that increase represented to the right (red). Yellow heat maps show the
corresponding frequency of normalized TF binding within 20 kb of these 100-
gene binned groups. Association with TF binding was highly significant
(Mann-Whitney test, P 1.36 109 for cooccupied sites) for the top decile
of transcripts that are altered in Cdx2/; Hnf4a/ intestines, relative to
those that are unchanged; this implies that both CDX2 and HNF4A activate
genes.
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highly skewed toward the lower left quadrant (Fig. 6G). The
strong association between reduced HNF4A binding and loss of
active chromatin inCdx2/ intestines implies that HNF4A relies
indirectly on a CDX2-dependent chromatin state for access to
DNA. Of note, loss of HNF4A binding in Cdx2/ intestines had
no relationship to the distance between CDX2 and HNF4A bind-
ing sites.
General effect of CDX2 deficiency on intestinal cell chroma-
tin in vivo. The dependence of chromatin states on CDX2 has
important implications for its function as a master regulator of
intestinal fate and function (14–18), especially if this dependence
represents a general mechanism for chromatin access at intestinal
genes. To address this possibility, we considered the more than
9,000 sites that CDX2 occupies without nearbyHNF4A binding in
intestinal villus cells (Fig. 1A).Wenoted first that, althoughCDX2
provides the bulk of Caudal-family protein activity in the gut (19,
48), phenotypic defects are more severe in Cdx1/; Cdx2/
than inCdx2/ intestine (18), indicating some functional redun-
dancy between CDX2 and CDX1. To determine whether CDX1
contributes to maintaining enhancer chromatin structure at
CDX2-occupied sites, we measured nucleosomal H3K4me2 in
mouse intestines deficient in both CDX1 and CDX2. H3K4me2
enrichment flanking CDX2 binding sites, already reduced in
Cdx2/ intestines, was further diminished in Cdx1/; Cdx2/
intestinal cells (Fig. 7A to C). Thus, CDX factors jointly maintain
permissive chromatin at thousands of intestinal enhancers in vivo,
including those that HNF4A does not occupy.
Lastly, we examined the degree to which maintaining active
chromatin is a general activity of CDX2, beyond regions where it
binds DNA near HNF4A. Comparative analysis of WT and
Cdx2/ intestinal cells revealed as profound a deficiency of
H3K4me2-marked chromatin in regions of CDX2 binding with-
out HNF4A as in those with HNF4A cooccupancy (Fig. 7D, left
and center columns). This marked deficit of active chromatin in
Cdx2/ intestines does not represent a global disturbance be-
cause thousands of H3K4me2-enriched nucleosomes were pre-
served in mutant Cdx2/ intestines (Fig. 7D, right column).
Moreover, active chromatin appeared at hundreds of new sites
(Fig. 7E, note the H3K4me2 chromatin distribution with NSD
scores of0), and the distribution of CDX2-occupied regions in
WT cells (Fig. 7E, red bars) coincided significantly with that of
negative NSD scores, signifying less marked chromatin, in Cdx
mutants. Furthermore, DNA binding and chromatin modulation
are probably sequence-specific actions because CDX2-dependent
chromatin regions were significantly enriched for CDX2-binding
motifs. In contrast, regions with increased H3K4me2-marked
nucleosomes in Cdx2/ intestines lacked enrichment of CDX2-
binding motifs and probably represent the actions of other tran-
scriptional regulators upon CDX2 loss.
FIG 4 HNF4A binding is dispensable for CDX2 occupancy of intestinal epithelial cell DNA. Binding of CDX2 was assessed in the absence of HNF4A. (A) CDX2
immunostaining confirms that its expression is unaffected inHnf4a/ intestines. (B) Composite ChIP-Seq plots of all regions bound only by CDX2 (left) or by
both CDX2 and HNF4A (right). DNA occupancy of CDX2 is similar in wild-type andHnf4a/ cells, with a very minor diminution in binding in mutant cells.
(C) In a site-for-site comparison of normalizedChIP-Seq tag counts, theminor changes inCDX2binding are similar among sites bound only byCDX2or by both
TFs (Mann-Whitney test, P  0.13). Box plots show the log2 fold difference of the normalized CDX2 ChIP-Seq read counts between WT and Hnf4a-null
intestines, at cooccupied and CDX2-only binding sites. The middle bar indicates the median of the distribution, and the lower and upper edges represent 25%
and 75% quartiles, respectively. Whiskers represent the lower (1.5 interquantile range) and upper (1.5 interquantile range) edges. Circles beyond the
whiskers are outliers. (D) A representative data trace from chromosome 16 position 22120000 to 22180000 illustrates preserved CDX2 binding inHnf4a/cells.
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FIG 5 CDX2 is necessary forHNF4A to bind intestinal epithelial cell DNA at cooccupied regions. (A) Immunoblotting and immunohistochemical evidence that
HNF4A levels are reduced, approximately by half, in Cdx2/ intestinal epithelium. (B) Four prominent CDX2 binding sites are observed in a 40-kb window at
themurineHnf4a locus, suggesting direct effects onHnf4a expression (P 105). (C) Composite plots of ChIP-Seq data fromWT andCdx2/ intestinal cells,
showing HNF4A occupancy at all regions where HNF4A binds DNAwithout (left box) or with (right box) nearby CDX2 binding. Aggregate HNF4A binding to
DNA is reduced, probably owing to lower protein levels, and the compromise is substantially larger at sites cooccupied by CDX2 (right box). Dotted lines mark
the difference in average HNF4A peak heights in WT and Cdx2/ intestines. (D and E) Selective losses in HNF4A binding are shown at representative regions
containing both HNF4A-only and cooccupied sites (D, chromosome 19 position 11085000 to 11160000; E, chromosome 7 position 88720000 to 88856000). In
Cdx2/ cells, HNF4A occupancy is affected less or not at all at sites without CDX2 binding (arrowheads) and severely compromised at sites where both TFs
normally cooccupy DNA (arrows). (F) Statistical evidence (Mann-Whitney test) that changes in HNF4A binding in the absence of CDX2 are more severe at
cooccupied than at singly bound sites.
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DISCUSSION
Some TFs are expressed briefly during development and impart
competence for tissue-restricted transcriptional programs. Such
TFs operationally resemble pioneer factors, which specify cell lin-
eages but seem to have a limited role inmaintaining stable cellular
or chromatin states beyond development (4). Instead, transcrip-
tion-permissive chromatin at cell-specific cis-regulatory modules
in adult tissues is thought to reflect the cooperative activity of
multiple TFs, with no single factor dominating materially over
others that occupy the same enhancer (4–7). In an important
sense, however, the well-studied examples that support this view
are not easily reconciled with the seemingly dominant biological
activities of lineage-specifying TFs. Such tissue-restricted factors
are classically exemplified bymyogenic and hematopoietic TFs (9,
11) but are also recognized in most other tissues; they often help
specify a cell lineage during development and maintain the same
FIG6 CDX2 loss adversely affects the active chromatin configuration at sites ofHNF4A cooccupancy. (A toC)NucleosomalH3K4me2 profiles were determined
byChIP-Seq ofMNase-digested chromatin fromWTandTF-depleted intestines. Aggregate plots of theChIP-Seq signal are centered on the 1,657 sites that CDX2
and HNF4A cooccupy inWTmice and also carry the H3K4me2mark of active enhancers. Loss of HNF4A did not affect the nucleosomal H3K4me2 profile (A),
whereas CDX2 loss prominently reducedH3K4me2 signals (B). Additional loss of HNF4A did not further affect theH3K4me2 profile ofCdx2/ tissue (C). (D)
Representative ChIP-Seq data from a region on chromosome 1. CDX2 loss compromised both chromatin structure and HNF4A binding, specifically at a
cooccupied site (bold dashed lines, asterisk), sparing the H3K4me2mark where it appears without CDX2 binding (light dashed lines), both within and far from
a promoter. See also Fig. S2 in the supplemental material. (E) Frequency of HNF4A-CDX2 cooccupied sites in WT (purple) and of HNF4A binding sites in
Cdx2/ (black) intestinal cells plotted in relation to the nucleosome stabilization-destabilization (NSD) score, a measure of altered H3K4me2-marked
chromatin in Cdx2/ intestines. Regions with reduced chromatin access in the absence of CDX2, represented to the right, correspond to those that CDX2 and
HNF4A cooccupy in WT intestines. Regions that are unchanged (center) or have become more accessible in Cdx2/ gut, represented to the left, show no
correlation with CDX2 and HNF4A binding. (F and G) Changes in nucleosomal H3K4me2 configuration at the 1,657 cooccupied regions were plotted against
the corresponding change in binding of CDX2 or HNF4A in mouse intestines lacking the other TF. Hnf4a-null intestine (F) showed little change in CDX2
occupancy (y axis) or chromatin configuration (x axis), whereas active chromatin andHNF4A binding were proportionately compromised inCdx2/ intestine
(G). Thus, CDX2 protects active chromatin at hundreds of regions, and HNF4A binding is preferentially diminished in the regions of highest chromatin effect
in Cdx2/ intestines.
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cell type in adults. CDX2 represents this class of master regulator
TFs in the intestine because it induces an intestine-specific tran-
scriptional program in heterologous stomach cells in vivo (15, 49),
specifies the developing intestine (14), and maintains adult intes-
tinal integrity and function (16–18). Recent work highlights the
additional activity of master regulator TFs in tailoring tissue-spe-
cific transcriptional programs in response to ubiquitous intercel-
lular signals such as Wnt and transforming growth factor 

(TGF-
) (12, 13, 50).
Together, the powerful biological activities of lineage specifi-
cation, cell maintenance, and cell-specific response suggest the
possibility of a dominant role for such proteins within TF hierar-
chies. However, it is unclear how that role is enacted at the level of
regulatory cis elements, nor has a role been demonstrated unam-
FIG 7 CDX1 and CDX2 jointly maintain the chromatin state at thousands of intestinal enhancers, beyond those occupied byHNF4A. (A and B) Aggregate plots
of enhancerH3K4me2 profiles inmutant intestines at CDX2-bound regions that lackHNF4A binding. TheH3K4me2mark on positioned nucleosomes flanking
CDX2 occupancy is considerably depleted inCdx2/ (A) and further compromised inCdx1/;Cdx2/ (B) intestinal cells, revealing a profound requirement
for Caudal family proteins in maintaining active chromatin in the adult gut. (C) A representative genomic region (chromosome 18 position 32187000 to
32215000) containing Myo7b illustrates progressive reduction in the H3K4me2 mark upon loss of CDX proteins. This is evident at regions that flank CDX2
binding sites both upstream and downstream (regions bracketed by dotted lines) of the TSS, whereas H3K4me2 levels at the Myo7b promoter (arrow) are
unaffected. (D) Distributions of the magnitude of changes in H3K4me2-marked chromatin following CDX2 loss. Sites that bind CDX2 without HNF4A are
affected asmuch byCDX2 loss as those that CDX2 andHNF4 cooccupy; both classes of binding regions suffer compared to regions where neither TF bindsDNA.
(E) CDX2 effects on chromatin are local rather than global. Regions that normally contain positioned H3K4me2-marked nucleosome pairs but do not bind
CDX2 or HNF4A show a normal distribution of changes after CDX2 loss (gray histogram). Althoughmost areas of the genome were unchanged and chromatin
was marked more strongly at many sites (NSD of 0), regions that bind CDX2 in WT intestines (red shading) had the most severely affected chromatin in
Cdx1/; Cdx2/ intestinal cells. The difference in distributions of the two histograms has a P value of 2.67 10156 by the two-sample t test.
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biguously with respect to chromatin and other TFs inmammalian
cells in vivo. Our results reveal a cardinal requirement for CDX2 in
maintaining enhancer chromatin in an active form at thousands
of sites in the genome of adult mouse intestinal cells. CDX2 pro-
tects or provides the active H3K4me2-marked chromatin config-
uration near most of its TSS-distal binding sites that show en-
hancer properties. Furthermore, nearby HNF4A binding, present
at about one in four such sites, is markedly compromised when
the H3K4me2 mark is attenuated in the absence of CDX2.
Whereas the Saccharomyces cerevisiae PHO5 promoter offered a
precedent for a similar TF function in enabling chromatin access
(51, 52), our study reveals the genome-wide activity of a lineage-
specifying TF in a mammalian tissue in vivo.
Loss of CDX2’s companion factor HNF4A did not materially
affect nucleosomal H3K4me2marks at thousands of sites where it
occupies DNA, regardless of nearby CDX2 binding. Rather, our
data reveal a hierarchy in which CDX2 governs access of other TFs
by controlling enhancer chromatin structure. Through this pow-
erful effect on chromatin, which we observed at the majority of
CDX2-bound sites in intestinal villus epithelial cells, CDX2might
also enable TFs other than HNF4A to access DNA. However, our
experiments do not address if CDX2 only maintains permissive
chromatin or is also responsible for initiating chromatin access in
nascent epithelial cells or in the embryonic gut, i.e., whether it
behaves as a bona fide pioneer factor. This is an important topic
for future investigation, together with the question of whether
CDX2 controls chromatin in a manner similar to the yeast PHO5
promoter (51, 52) or through mechanisms that may be unique to
complex mammalian enhancers. Most importantly, CDX2’s pro-
found role in preserving enhancer activity in an adult organ in vivo
suggests that master regulators of other cell lineages may control
tissue-specific genes by similarly maintaining chromatin in an ac-
tive configuration at distant, lineage-restricted enhancers.
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